Frontlight ResearchEarly access
Trial site
Chao Family Comprehensive Cancer Center and Ambulatory Care
- 6running trials
- 1closed trial
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Pancreatic cancer2 trials
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Multiple myeloma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting5 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Pfizer5 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Liver and biliary tract cancer2 recruiting
- Pancreatic cancer2 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026